Patent: 10,030,051

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,030,051

Title:	Antibody targeting through a modular recognition domain
Abstract:	The present invention provides antibodies containing one or more modular recognition domains (MRDs) for targeting the antibodies to specific sites. The use of the antibodies containing one or more modular recognition domains to treat disease, and methods of making antibodies containing one or more modular recognition domains are also provided in the invention.
Inventor(s):	Barbas, III; Carlos F. (La Jolla, CA)
Assignee:	The Scripps Research Institute (La Jolla, CA)
Application Number:	14/963,722
Patent Claims:	see list of patent claims

Details for Patent 10,030,051

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Genentech Inc	HERCEPTIN HYLECTA	trastuzumab; hyaluronidase-oysk	INJECTABLE;SUBCUTANEOUS	761106	001	2019-02-28	Start Trial	The Scripps Research Institute (La Jolla, CA)	2028-01-03	RX		search
Genentech	HERCEPTIN	trastuzumab	VIAL; INTRAVENOUS	103792	001	1998-09-25	Start Trial	The Scripps Research Institute (La Jolla, CA)	2028-01-03	RX	Orphan	search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patent Family for US Patent 10,030,051

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201004730	Start Trial
World Intellectual Property Organization (WIPO)	2009088805	Start Trial
World Intellectual Property Organization (WIPO)	2012009705	Start Trial
United States of America	10087222	Start Trial
United States of America	2011189206	Start Trial
United States of America	2012020966	Start Trial
United States of America	2012020967	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.